Human TNFRSF18 / GITR / CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR, Research Use)

产品名称	Human TNFRSF18 / GITR / CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR, Research Use)
目录号	NBR-0693
别名	AITR; CD357; GITR
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0693-100UG	100ug	￥550	请咨询
NBR-0693-1MG	1mg	￥3500	请咨询
NBR-0693-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human TNFRSF18 / GITR / CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR, Research Use)
产品编号：NBR-0693
针对靶点：TNFRSF18 / GITR / CD357
抗体药商品名：Korea Natl.Cancer Ctr. patent anti-GITR
抗体药描述：The drug is a recombinant fully human anti-GITR monoclonal antibody, being developed by Korea Natl.Cancer Ctr..

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: TNFRSF18
Synonyms: AITR; CD357; GITR
Target Description: Receptor for TNFSF18. Seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. Mediated NF-kappa-B activation via the TRAF2/NIK pathway.
Ensembl: ENSG00000186891
Uniprot: Q9Y5U5